Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Xechem Buys Ceptor, Adds Size To Niche Drug Pipeline

Dec. 31, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche

Dec. 17, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...